Thursday, 29 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Adverse Business Impact

Mangalam Drugs and Organics Adverse Business Impact

Mangalam Drugs and Organics Limited reported a combined default of ₹15.58 Crore on cash credit facilities from Bank of Maharashtra and Bank of Baroda. The defaults began in October 2025. The company stated it is making arrangements to pay the overdue amounts as soon as possible.

Key figures
Value₹15.58 Cr
Source

BSE filing, NSE: MANGALAM. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Mangalam Drugs and Organics Ltd: key numbers

Share price
₹29.11
Market cap
₹46.08 Cr
Revenue (annual)
₹232.1 Cr
Net profit (annual)
₹-44.40 Cr
P/E (TTM)
-1.2×Sector 46.1×
Promoter holding
35.65%+0.00% QoQ
FII holding
0.11%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Mangalam Drugs and Organics Ltd

All →

Other adverse business impact announcements

All →